- Home
- GPCR vs CNNE Comparison
GPCR vs CNNE Comparison
Compare GPCR & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- CNNE
- Stock Information
- Founded
- GPCR 2016
- CNNE 2014
- Country
- GPCR United States
- CNNE United States
- Employees
- GPCR N/A
- CNNE N/A
- Industry
- GPCR
- CNNE Restaurants
- Sector
- GPCR
- CNNE Consumer Discretionary
- Exchange
- GPCR Nasdaq
- CNNE Nasdaq
- Market Cap
- GPCR 1.1B
- CNNE 1.1B
- IPO Year
- GPCR 2023
- CNNE N/A
- Fundamental
- Price
- GPCR $21.76
- CNNE $18.66
- Analyst Decision
- GPCR Strong Buy
- CNNE Buy
- Analyst Count
- GPCR 8
- CNNE 2
- Target Price
- GPCR $79.29
- CNNE $22.00
- AVG Volume (30 Days)
- GPCR 755.1K
- CNNE 647.9K
- Earning Date
- GPCR 05-08-2025
- CNNE 05-12-2025
- Dividend Yield
- GPCR N/A
- CNNE 2.57%
- EPS Growth
- GPCR N/A
- CNNE N/A
- EPS
- GPCR N/A
- CNNE N/A
- Revenue
- GPCR N/A
- CNNE $445,000,000.00
- Revenue This Year
- GPCR N/A
- CNNE N/A
- Revenue Next Year
- GPCR N/A
- CNNE $1.91
- P/E Ratio
- GPCR N/A
- CNNE N/A
- Revenue Growth
- GPCR N/A
- CNNE N/A
- 52 Week Low
- GPCR $13.22
- CNNE $15.92
- 52 Week High
- GPCR $62.74
- CNNE $22.36
- Technical
- Relative Strength Index (RSI)
- GPCR 39.75
- CNNE 57.62
- Support Level
- GPCR $22.09
- CNNE $17.43
- Resistance Level
- GPCR $24.98
- CNNE $19.03
- Average True Range (ATR)
- GPCR 1.64
- CNNE 0.54
- MACD
- GPCR -0.54
- CNNE 0.06
- Stochastic Oscillator
- GPCR 4.64
- CNNE 75.15
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.